Ronnie van der Holt

Ronnie van der Holt is a Researcher at Erasmus MC, Hematology Department, Erasmus University Rotterdam. His research focuses on hematological malignancies, clinical trial methodologies, and translational oncology. Key areas include multiple myeloma, lymphoma, and interventional oncology procedures.

He contributes to large-scale randomized controlled trials such as TESLA RCT (biliary obstruction management) and HOVON series (lymphoma/immunosuppression studies). His work spans drug efficacy evaluation, long-term patient outcomes, and novel therapeutic protocols. Collaborations include Nordic Lymphoma Group and HOVON Stem Cell Transplantation Working Group.

Recent articles highlight advancements in stent technologies for biliary obstructions, cost-effectiveness of music therapy in neurosurgical care, and long-term survival analysis in myeloma patients. His research integrates clinical, pharmacological, and economic dimensions of cancer treatment.